Mary Fenton
Director of Finance/CFO at CULLINAN THERAPEUTICS, INC.
Net worth: 108 880 $ as of 30/04/2024
Mary Fenton active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CULLINAN THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 29/04/2024 | - |
| Director of Finance/CFO | 29/04/2024 | - | |
Connecticut Business & Industry Association
 Connecticut Business & Industry Association Miscellaneous Commercial ServicesCommercial Services Connecticut Business & Industry Association is a non-profit organization that provides commercial support services. The private company is based in Hartford, CT. Joseph F. Brennan has been the CEO of the company since 1988. | Director/Board Member | 06/12/2018 | - |
| Chairman | - | 06/12/2018 |
Career history of Mary Fenton
Former positions of Mary Fenton
| Companies | Position | Start | End |
|---|---|---|---|
| ONCORUS, INC. | Director/Board Member | 20/12/2019 | 27/07/2023 |
| Independent Dir/Board Member | 20/12/2019 | 27/07/2023 | |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01/10/2019 | 01/02/2021 |
Semma Therapeutics, Inc.
 Semma Therapeutics, Inc. BiotechnologyHealth Technology Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA. | Chief Operating Officer | 01/05/2019 | 01/10/2019 |
| Director of Finance/CFO | 01/05/2019 | 01/10/2019 | |
| ACHILLION PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/01/2006 | 28/12/2018 |
| Director of Finance/CFO | 01/01/2006 | 28/12/2018 | |
| Investor Relations Contact | 01/10/2000 | 15/08/2018 | |
| Corporate Secretary | 01/10/2000 | 01/02/2016 | |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Corporate Officer/Principal | 01/08/1991 | 01/10/2000 |
| TOURMALINE BIO, INC. | Chief Executive Officer | 26/05/2023 | - |
| Director of Finance/CFO | 01/03/2021 | - | |
| President | 26/05/2023 | - |
Training of Mary Fenton
| College of the Holy Cross (Massachusetts) | Undergraduate Degree |
| University of Connecticut School of Business | Masters Business Admin |
Statistics
International
| United States | 10 |
| New Zealand | 2 |
Operational
| Director of Finance/CFO | 4 |
| Comptroller/Controller/Auditor | 2 |
| Corporate Officer/Principal | 2 |
Sectoral
| Health Technology | 7 |
| Commercial Services | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| ONCORUS, INC. | Health Technology |
| CULLINAN THERAPEUTICS, INC. | Health Technology |
| Private companies | 5 |
|---|---|
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
Connecticut Business & Industry Association
Connecticut Business & Industry Association Miscellaneous Commercial ServicesCommercial Services Connecticut Business & Industry Association is a non-profit organization that provides commercial support services. The private company is based in Hartford, CT. Joseph F. Brennan has been the CEO of the company since 1988. | Commercial Services |
Semma Therapeutics, Inc.
Semma Therapeutics, Inc. BiotechnologyHealth Technology Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA. | Health Technology |
Talaris Therapeutics, Inc.
 Talaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talaris Therapeutics, Inc. is a late-clinical stage cell therapy company, which engages in the development of allogeneic hematopoietic stem cell transplantation. The company was founded by Suzanne Ildstad on February 15, 2002 and is headquartered in Wellesley, MA. | Health Technology |
- Stock Market
- Insiders
- Mary Fenton
- Experience